Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost-Reference-Cited by-同舟云学术

Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost

Published:2021-01 Issue: Volume:154 Page:29-35
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Alayed Yasir,Loblaw Andrew,McGuffin Merrylee,Chung Hans T.,Tseng Chia-Lin^ORCID,D'Alimonte Laura,Cheung Patrick,Liu Stanley^ORCID,Chu William^ORCID,Szumacher Ewa,Helou Joelle,Ravi Ananth,Haider Masoom,Mamedov Alexandre^ORCID,Zhang Liying^ORCID,Morton Gerard^ORCID

Funder

Canadian Association of Radiation Oncology

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference21 articles.

1. High dose-rate brachytherapy in the treatment of prostate cancer;Mendez;Transl Androl Urol,2018

2. High-dose-rate brachytherapy as monotherapy for prostate cancer;Demanes;Brachytherapy,2014

3. Favorable preliminary outcomes for men with low- and intermediate-risk prostate cancer treated with 19-Gy single-fraction high-dose-rate brachytherapy;Krauss;Int J Radiat Oncol,2017

4. Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer;Hoskin;Radiother Oncol,2017

5. High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: toxicity and long-term biochemical results;Prada;Radiother Oncol,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single–dose high-dose-rate brachytherapy versus two and three fractions for locally advanced prostate cancer;Radiotherapy and Oncology;2024-10

2. Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer;Brachytherapy;2024-09

3. Brachytherapy based microboosting to the dominant intraprostatic lesion in prostate cancer: A systematic review on treatment outcomes and toxicities;Brachytherapy;2024-09

4. High-dose-rate Brachytherapy Monotherapy in Patients With Localised Prostate Cancer: Dose Modelling and Optimisation Using Computer Algorithms;Clinical Oncology;2024-06

5. The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer—Quo Vadimus?;World Journal of Urology;2023-11-03